Blood-cerebrospinal fluid barrier dysfunction for high molecular weight proteins in alzheimer disease and major depression: Indication for disease subsets

Alzheimer Disease and Associated Disorders

Volumn 11, Issue 2, 1997, Pages 78-87

  Hampel, H ^a,b   Kotter H U ^a   Moller H J ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Albumin ratio; Alzheimer disease; Blood brain barrier; Blood CSF barrier; IgG ratio; Immunoactivation; Major depression

Indexed keywords

IMMUNOGLOBULIN G; PROTEIN; SERUM ALBUMIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HOMEOSTASIS; HUMAN; IMMUNE SYSTEM; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MOLECULAR WEIGHT; NEUROPSYCHIATRY; ONSET AGE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL;

EID: 0342683872     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-199706000-00004     Document Type: Article

References (72)

1. Alafuzoff I, Adolfsson R, Bucht G, Winbald B. Albumin and immunoglobulin in plasma and cerebrospinal fluid, and blood-cerebrospinal fluid barrier function in patients with dementia of Alzheimer type and multi-infarct dementia. J Neurol Sci 1983;60:465-72.
2. Alafuzoff I, Adolfsson R, Grundke-Iqbal I, Winblad B. Perivascular deposits of serum proteins in cerebral cortex in vascular dementia. Acta Neuropathol (Berl) 1985;66:292-8.
3. Alafuzoff I, Adolfsson R, Grundke-Iqbal I, Winblad B. Blood-brain barrier in Alzheimer dementia and non-demented elderly. Acta Neuropathol 1987;73:160-6.
4. Balin BJ, Broadwell RD, Salcman M, El-Kalliny M. Avenues for entry of peripherally administered protein to the central nervous system in the mouse, rat and squirrel monkey. J Comp Neurol 1986;251:260-80.
5. Bauer J, Berger M. Neuropathologische, immunologische und psychobiologische Aspekte der Alzheimer Demenz. Fortschr Neurol Psychiatr 1993;61:225-40.
6. Ben Menachem E, Persson L, Schechter PJ, Haegele KD, Huebert N, Hardenberg J. Cerebrospinal fluid parameters in healthy volunteers during serial lumbar puncture. J Neurochem 1989;52:632-5.
7. Blennow K, Wallin A, Davidsson P, Fredman P, Gottfries CG, Svennerholm L. Intra-blood-brain-barrier-synthesis of immunoglobulins in patients with dementia of the Alzheimer's type. Alzheimer Dis Assoc Disord 1990;4:79-86.
8. Brightman MW, Reese TS. Junctions between intimately opposed cell membranes in the vertebrate brain. J Cell Biol 1969;40:648-77.
9. Chapel HM, Esiri MM, Wilcock GK. Immunoglobulin and other proteins in the cerebrospinal fluid of patients with Alzheimer's disease. J Clin Pathol 1984;37:697-9.
10. Cohen D, Eisdorfer C. Serum immunoglobulins and cognitive status in the elderly. I. A population study. Br J Psychiatry 1980;136:33-9.
11. Cserr HF, Knopf PM. Cervical lymphatics, the blood-brain-barrier and the immunoreactivity of the brain: a new view. Immunol Today 1992; 13(12):507-12.
12. Eaton LM. Comparisons of protein content of first and second portions of cerebrospinal fluid removed at lumbar puncture. Proc Staff Meet Mayo Clin 1939;14:661-3.
13. Elovaara I, Icén A, Palo J, Erkinjuntti T. CSF in Alzheimer's disease. Studies on blood-brain barrier function and intrathecal protein synthesis. J Neurol Sci 1985;70:73-80.
14. Fabian RH, Petroff G. Intraneuronal IgG in the central nervous system: uptake by retrograde axonal transport. Neurology 1987;37:1780-4.
15. Fabing HD. Progressive fall in protein content of cerebrospinal fluid withdrawn above a tumor of the cauda equina. Arch Neurol Psychiatr 1939:41:373-4.
16. Felgenhauer K. Differentiation of the humoral immune response in inflammatory diseases of the central nervous system. J Neurol 1982;228:223-37.
17. Fishman RA, Ransohoff J, Osserman EF. Factors influencing the concentration gradient of protein in cerebrospinal fluid. J Clin Invest 1958;37:1419-28.
18. Folstein M, Folstein S, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
19. Franceschi M, Comola M, Nunni R. Neuron-binding antibodies in Alzheimer's disease and Down's syndrome. J Gerontol 1989;44:128-30.
20. Friedland RP, Budinger TF, Jagust WJ, Yano Y, Huesman RH, Knittel B. Positron emission tomography and the blood-brain barrier in Alzheimer's disease. In: Cahn J, Lassen NA, eds. New brain imaging techniques in cerebrovascular diseases. London: Libbey Eurotext, 1985:85-93.
21. Friedland RP, Jagust WJ, Hnesman RH, et al. Regional cerebral glucose transport and utilization in Alzheimer's disease. Neurology 1989;39: 1427-34.
22. Glenner GG. Congophilic microangiopathy in the pathogenesis of Alzheimer's syndrome (presenile dementia). Med Hypotheses 1979;5: 1231-6.
23. Glenner GG. On causative theories in Alzheimer's disease. Hum Pathol 1985;16:433-5.
24. Glenner GG. On primal causes in Alzheimer's disease. Neurobiol Aging 1986;7:506-8.
25. Glenner GG, Henry JH, Fujihara S. Congophilic angiopathy in the pathogenesis of Alzheimer's degeneration. Ann Pathol 1981;2:120-9.
26. Glenner GG, Wong CW. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun 1984;122:1131-5.
27. Griffin WST, Stanley LC, Ling C, et al. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down's syndrome and Alzheimer disease. Proc Natl Acad Sci USA 1989;86:7611-5.
28. Hardy JA, Mann DMA, Wester P, Winblad B. An integrative hypothesis concerning the pathogenesis and progression of Alzheimer's disease. Neurobiol Aging 1986;7:489-502.
29. Hatterer JA, Herbert J, Hidaka C, Roose SP, Gorman JM. CSF transthyretin in patients with depression. Am J Psychiatry 1993;150(5):813-5.
30. Henderson AS, Henderson JH. Etiology of dementia of Alzheimer's type. Dahlem Konferenzen. Chichester, UK: Wiley, 1988.
31. Ishii T, Haga S. Immuno-electron microscopic localization of immunoglobulins in amyloid fibrils and senile plaques. Acta Neuropathol (Berl) 1976;36:243-9.
32. Ishii T, Haga S, Schimuzu F. Identification of components of immunoglobulins in senile plaques by means of fluorescent antibody technique. Acta Neuropathol (Berl) 1975;32:157-62.
33. Joachim CL, Mori H, Selkoe DJ. Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease. Nature 1989;341:226-30.
34. Jonker C, Eikelenboom P, Tavenier P. Immunological indices in the cerebrospinal fluid of patients with presenile dementia of the Alzheimer type. Br J Psychiatry 1982;140:44-9.
35. Kang J, Lemaire HG, Unterbeck A, et al. The precursor of Alzheimer's disease A4 protein resembles a cell-surface receptor. Nature 1987;325:733-6.
36. Kay AD, May C, Papadopoulos NM, et al. CSF and serum concentrations of albumin and IgG in Alzheimer's disease. Neurobiol Aging 1987;8:21-5.
37. Kornhuber J, Kaiserauer CH, Kornhuber AW, Kornhuber ME. Alcohol consumption and blood-cerebrospinal fluid barrier dysfunction in man. Neurosci Lett 1987;79:218-22.
38. Leonardi A, Gandolfo C, Arata L, Vecchia R. The integrity of the blood-brain barrier in Alzheimer's type and multi-infarct dementia by the study of albumin and IgG in serum and cerebrospinal fluid. J Neurol Sci 1985;67:253-61.
39. Levine B, Harwick JM, Trapp BD, Crawford TO, Bollinger RC, Griffin DE. Antibody-mediated clearance of alphavirus infection from neurons. Science 1991;254:856-60.
40. Mandlybur TI. The incidence of cerebral amyloid angiopathy in Alzheimer's disease. Neurology 1975;25:120-6.
41. Mann DMA. The neuropathology of Alzheimer's disease: a review with pathogenetic, aetiological, and therapeutic considerations. Mech Ageing Dev 1985;31:213-55.
42. Mann DMA, Davies J, Hawkes J, Yates PO. Immunohistochemistry staining of senile plaques. Neuropathol Appl Neurobiol 1982;8:55.
43. Mann DMA, Jones D, Prinja D, Purkiss MS. The prevalence of amyloid (A4) protein deposits within the cerebral and cerebellar cortex in Down's syndrome and Alzheimer's disease. Acta Neuropathol 1990;80:318-27.
44. Manila KM, Pirrtila I, Blennow K, Wallin A, Viitanen M, Frey H. Altered blood-brain-barrier function in Alzheimer's disease? Acta Neurol Scand 1994;89(3):192-8.
45. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: reports of the NINCDS-ADRDA workgroup under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44.
46. Mooradian AD. Effect of aging on the blood-brain-barrier. Neurobiol Aging 1988;9:31-9.
47. Mori S, Sternberger NH, Herman MM, Sternberger LA. Leakage and neuronal uptake of serum protein in aged and Alzheimer brains: a postmortem phenomenon with antemortem etiology. Lab Invest 1991;64(3):345-51.
48. Naber D, Perro S, Schielke E, Goebel FD, Hippius H. Neuropsychological deficits and other psychiatric symptoms in HIV-1 infected patients. In: Weis S, Hippius H, eds. HIV-1 infection of the central nervous system. Seattle, WA: Horgrefe & Huber Publishers, 1995.
49. Oehmichen M, Gencic M. Postmortal diffusion of plasma albumin in rat brain. Z Rechtsmed 1980;84:113.
50. Pardridge WM, Vinters HV, Miller BL, Tourtellotte WW, Eisenberg JB, Yang J. High molecular weight Alzheimer's disease amyloid peptide immunoreactivity in human serum and CSF is an immunoglobulin G. Biochem Biophys Res Commun 1987;145:241-8.
51. Perlmutter LS, ChangChui H. Microangiopathy, the vascular basement membrane and Alzheimer's disease. Brain Res Bull 1990;24:677-86.
52. Pitts AF, Carroll BT, Gehris TL, Kathol RG, Samuelson SD. Elevated CSF protein in male patients with depression. Biol Psychiatry 1990; 28(7):629-37.
53. Ranalli P, Bergeron C. Amyloid angiopathy in Alzheimer's disease. Ann Neurol 1984;16:119.
54. Rapoport SI. Passage of proteins from blood to CSF - model for transfer by pores and vesicles. In: Wood JH, ed. Neurobiology of cerebrospinal fluid 2. New York: Plenum Publishing Corporation, 1983:233-45.
55. Rapoport SI, Ohno K, Pettigrew KD. Blood-brain-barrier permeability in senescent rats. J Gerontol 1976;34:162-9.
56. Reiber H. The discrimination between blood-CSF barrier dysfunction and inflammatory reaction of the CNS by a recent evaluation graph for the protein profile of the cerebrospinal fluid. J Neurol 1990;224:89-99.
57. Rice GPA, Armstrong H, Ebers GC. Variation in immunoglobulin G and albumin concentrations during lumbar CSF removal: a reappraisal. Neurology 1982;32:893-4.
58. Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A. Pathologic verification of ischemic score in differentiation of dementias. Ann Neurol 1980;7:486-8.
59. Rudick RA, Buell SJ. Integrity of blood-brain-barrier to peroxidase in senescent mice. Neurobiol Aging 1983;4:283-7.
60. Samuelson SD, Winokur G, Pitts AF. TI: elevated cerebrospinal fluid protein in men with unipolar or bipolar depression. Biol Psychiatry 1994;35(8):539-44.
61. Schlageter NL, Carson RE, Rapoport SI. Examination of blood-brain barrier permeability in dementia of the Alzheimer type with *68Ga* EDTA and positron emission tomography. J Cereb Blood Flow Metab 1987;7:1-8.
62. Selkoe DJ. Physiological production of the β-amyloid protein and the mechanism of Alzheimer's disease. Trends Neurosci 1993;16:403-8.
63. Small GW, Rosenthal M, Tourtelotte WW. Central nervous system IgG synthesis rates in Alzheimer's disease: possible differences in early onset and late onset subgroups. Alzheimer Dis Assoc Disord 1994; 8:29-37.
64. Sparrow JR. Immunocytochemical localization of plasma proteins in neuronal perikarya. Neurosci Lett 1978;8:335-9.
65. Stein DP, Rudick RA. Variation in immunoglobulin G index and synthesis rate during lumbar CSF removal. Neurology 1986;36(Suppl 1):255.
66. Tanzi RE, Gusella JF, Watkins PC, et al. Amyloid beta protein gene: cDNA, mRNA distribution and genetic linkage near the Alzheimer locus. Science 1987;235:880-4.
67. Tibbling G, Link H, Ohman S. Principles of albumin and IgG analyses in neurological disorders. 1. Establishment of reference values. Scand J Clin Lab Invest 1977;37:385-90.
68. Tomlinson BE, Blessed G, Roth M. Observations on the brains of demented old people. J Neurol Sci 1970;11:205-42.
69. Vinters HV, Pardridge WM. The blood brain barrier in Alzheimer's disease. Can J Neurol Sci 1986;13:446-8.
70. Weisner B, Bernhardt W. Protein fractions of lumbar, cisternal, and ventricular cerebrospinal fluid: separate areas of references. J Neurol Sci 1978;37:205-14.
71. Wisniewski HM, Kozlowski PB. Evidence for blood-brain barrier changes in senile dementia of the Alzheimer type (SAD). In: Sinex FM, Merril CR, eds. Alzheimer's disease, Down s syndrome and aging. Annals of the New York Academy of Sciences, vol. 396. New York: New York Academy of Sciences, 1982:119-29.
72. Wurster U. Protein gradients in the cerebrospinal fluid and the calculation of intracerebral IgG synthesis. J Neuroimmunol 1988;20:233-5.